Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells (Q43607162)

25 November 2017

Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells (English)

1 reference

25 November 2017

0 references

M M Muthalif

1

1 reference

25 November 2017

M R Uddin

2

1 reference

25 November 2017

S Fatima

3

1 reference

25 November 2017

J H Parmentier

4

1 reference

25 November 2017

Z Khandekar

5

1 reference

25 November 2017

K U Malik

6

1 reference

25 November 2017

1 May 2001

1 reference

Prostaglandins and Other Lipid Mediators

25 November 2017

1 reference

25 November 2017

65

1 reference

25 November 2017

1

1 reference

25 November 2017

33-43

1 reference

Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Replication of smooth muscle cells in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Calcium/calmodulin-dependent protein kinase IIalpha mediates activation of mitogen-activated protein kinase and cytosolic phospholipase A2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Phospholipase A2-mediated activation of mitogen-activated protein kinase by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

A potential role for extracellular signal-regulated kinases in prostaglandin F2alpha-induced protein synthesis in smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Alpha1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Protein prenylation: molecular mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Pharmacology of smooth muscle cell replication

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

The EGF receptor as central transducer of heterologous signalling systems

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Ras-Cdc25 and Rho-Dbl binding assays: complex formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

The Ras mutant D119N is both dominant negative and activated

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

A farnesyl-protein transferase inhibitor induces p21 expression and G1 block in p53 wild type tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

Cell cycle progression: new therapeutic target for vascular proliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900112-5

7 January 2021

10.1016/S0090-6980(01)00112-5

Identifiers

DOI

1 reference

25 November 2017

1 reference